250 related articles for article (PubMed ID: 35856557)
21. Single-cell transcriptomics in bone marrow delineates CD56
Melsen JE; van Ostaijen-Ten Dam MM; Schoorl DJA; Schol PJ; van den Homberg DAL; Lankester AC; Lugthart G; Schilham MW
Front Immunol; 2022; 13():1044398. PubMed ID: 36505452
[TBL] [Abstract][Full Text] [Related]
22. A New Hope for CD56
Forconi CS; Oduor CI; Oluoch PO; Ong'echa JM; Münz C; Bailey JA; Moormann AM
Front Cell Infect Microbiol; 2020; 10():162. PubMed ID: 32373555
[TBL] [Abstract][Full Text] [Related]
23. Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular Carcinoma.
Rennert C; Tauber C; Fehrenbach P; Heim K; Bettinger D; Sogukpinar Ö; Schuch A; Zecher BF; Bengsch B; Lang SA; Bronsert P; Björkström NK; Fichtner-Feigl S; Schultheiss M; Thimme R; Hofmann M
Cells; 2021 Jun; 10(6):. PubMed ID: 34199483
[TBL] [Abstract][Full Text] [Related]
24. Accumulation of Tumor-Infiltrating CD49a
Sun H; Liu L; Huang Q; Liu H; Huang M; Wang J; Wen H; Lin R; Qu K; Li K; Wei H; Xiao W; Sun R; Tian Z; Sun C
Cancer Immunol Res; 2019 Sep; 7(9):1535-1546. PubMed ID: 31311791
[TBL] [Abstract][Full Text] [Related]
25. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients.
Cai L; Zhang Z; Zhou L; Wang H; Fu J; Zhang S; Shi M; Zhang H; Yang Y; Wu H; Tien P; Wang FS
Clin Immunol; 2008 Dec; 129(3):428-37. PubMed ID: 18824414
[TBL] [Abstract][Full Text] [Related]
26. [Characteristics of peripheral NK cells in hepatocellular carcinoma patients].
Zhou L; Cai L; Zhang Z; Yang YP; Wang FS
Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):136-9. PubMed ID: 20196954
[TBL] [Abstract][Full Text] [Related]
27. Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.
Sun C; Sun HY; Xiao WH; Zhang C; Tian ZG
Acta Pharmacol Sin; 2015 Oct; 36(10):1191-9. PubMed ID: 26073325
[TBL] [Abstract][Full Text] [Related]
28. Circular RNA profiling identifies circADAMTS13 as a miR-484 sponge which suppresses cell proliferation in hepatocellular carcinoma.
Qiu L; Huang Y; Li Z; Dong X; Chen G; Xu H; Zeng Y; Cai Z; Liu X; Liu J
Mol Oncol; 2019 Feb; 13(2):441-455. PubMed ID: 30537115
[TBL] [Abstract][Full Text] [Related]
29. Role of chemokines in the biology of natural killer cells.
Maghazachi AA
Curr Top Microbiol Immunol; 2010; 341():37-58. PubMed ID: 20369317
[TBL] [Abstract][Full Text] [Related]
30. Novel insights on human NK cells' immunological modalities revealed by gene expression profiling.
Hanna J; Bechtel P; Zhai Y; Youssef F; McLachlan K; Mandelboim O
J Immunol; 2004 Dec; 173(11):6547-63. PubMed ID: 15557145
[TBL] [Abstract][Full Text] [Related]
31. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
Cheung PF; Yip CW; Wong NC; Fong DY; Ng LW; Wan AM; Wong CK; Cheung TT; Ng IO; Poon RT; Fan ST; Cheung ST
Cancer Immunol Res; 2014 Dec; 2(12):1209-19. PubMed ID: 25315249
[TBL] [Abstract][Full Text] [Related]
32. Identification of SGMS2 as a molecule involved in natural killer cell recruitment and its in-deep analysis in the liver cancer microenvironment: Evidence from large populations cohort.
Tang W; Meng F; Li M; Li Y; Xiong W; Zhang D; Yang B
J Gene Med; 2024 Jan; 26(1):e3609. PubMed ID: 37849429
[TBL] [Abstract][Full Text] [Related]
33. The Prognostic Value of Natural Killer Cells and Their Receptors/Ligands in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Xue JS; Ding ZN; Meng GX; Yan LJ; Liu H; Li HC; Yao SY; Tian BW; Dong ZR; Chen ZQ; Hong JG; Wang DX; Li T
Front Immunol; 2022; 13():872353. PubMed ID: 35464489
[TBL] [Abstract][Full Text] [Related]
34. Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
Krijgsman D; de Vries NL; Skovbo A; Andersen MN; Swets M; Bastiaannet E; Vahrmeijer AL; van de Velde CJH; Heemskerk MHM; Hokland M; Kuppen PJK
Cancer Immunol Immunother; 2019 Jun; 68(6):1011-1024. PubMed ID: 31053876
[TBL] [Abstract][Full Text] [Related]
35. Natural Killer Cell Dysfunction in Hepatocellular Carcinoma: Pathogenesis and Clinical Implications.
Sung PS; Jang JW
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463262
[TBL] [Abstract][Full Text] [Related]
36. Tumor infiltrating NK cell (TINK) subsets and functional molecules in patients with breast cancer.
Rezaeifard S; Talei A; Shariat M; Erfani N
Mol Immunol; 2021 Aug; 136():161-167. PubMed ID: 34171565
[TBL] [Abstract][Full Text] [Related]
37. Hsa_circ_0007456 regulates the natural killer cell-mediated cytotoxicity toward hepatocellular carcinoma via the miR-6852-3p/ICAM-1 axis.
Shi M; Li ZY; Zhang LM; Wu XY; Xiang SH; Wang YG; Zhang YQ
Cell Death Dis; 2021 Jan; 12(1):94. PubMed ID: 33462208
[TBL] [Abstract][Full Text] [Related]
38. Immunophenotypes and cytotoxic functions of lymphocytes in patients with hepatocellular carcinoma.
Chavan SS; Chiplunkar SV
Tumori; 1997; 83(4):762-7. PubMed ID: 9349318
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxicity of Human Hepatic Intrasinusoidal CD56
Hwang S; Han J; Baek JS; Tak E; Song GW; Lee SG; Jung DH; Park GC; Ahn CS; Kim N
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925759
[TBL] [Abstract][Full Text] [Related]
40. Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells.
Tsunematsu H; Tatsumi T; Kohga K; Yamamoto M; Aketa H; Miyagi T; Hosui A; Hiramatsu N; Kanto T; Hayashi N; Takehara T
Int J Cancer; 2012 Jan; 130(2):356-64. PubMed ID: 21351090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
